33,476 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by Proficio Capital Partners LLC

Proficio Capital Partners LLC purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 33,476 shares of the pharmacy operator’s stock, valued at approximately $312,000.

Several other institutional investors have also modified their holdings of the business. Farther Finance Advisors LLC lifted its position in Walgreens Boots Alliance by 56.0% in the third quarter. Farther Finance Advisors LLC now owns 5,831 shares of the pharmacy operator’s stock worth $52,000 after purchasing an additional 2,094 shares during the period. QRG Capital Management Inc. lifted its position in Walgreens Boots Alliance by 85.9% in the third quarter. QRG Capital Management Inc. now owns 31,706 shares of the pharmacy operator’s stock worth $284,000 after purchasing an additional 14,651 shares during the period. Principal Financial Group Inc. lifted its position in Walgreens Boots Alliance by 2.9% in the third quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator’s stock worth $7,940,000 after purchasing an additional 24,974 shares during the period. CWA Asset Management Group LLC acquired a new stake in Walgreens Boots Alliance in the third quarter worth approximately $106,000. Finally, Mesirow Financial Investment Management Inc. lifted its position in Walgreens Boots Alliance by 73.9% in the third quarter. Mesirow Financial Investment Management Inc. now owns 79,108 shares of the pharmacy operator’s stock worth $709,000 after purchasing an additional 33,629 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.6 %

Walgreens Boots Alliance stock opened at $11.21 on Wednesday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm’s fifty day moving average price is $10.71 and its two-hundred day moving average price is $9.73. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The firm has a market capitalization of $9.69 billion, a price-to-earnings ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company’s revenue was up 7.6% on a year-over-year basis. During the same quarter last year, the company earned $0.66 earnings per share. On average, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of research analyst reports. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Royal Bank of Canada increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.